clinical trial · NCT07742852
ASKC200 for Knee Osteoarthritis Pain
Jiangsu Aosaikang Pharmaceutical Co., Ltd.·phase2·active not recruiting·n = 175
Osteoarthritis (OA) of the KneePain5% ASKC2001% Diclofenac Diethylamine EmulgelPlacebo1% ASKC200
brief summary
This is a Phase II clinical trial designed to evaluate the efficacy and safety of ASKC200 Lotion in patients with knee osteoarthritis (KOA) pain. A total of 175 eligible patients will be randomly assigned to three groups at a 1:2:2:2 ratio: the experimental group1 (treated with 1% ASKC200 Lotion), the experimental group 2(treated with 5% ASKC200 Lotion), the active control group (treated with Diclofenac Diethylamine Emulgel), and the placebo group (treated with matching placebos).
started
Sep 12, 2025
primary completion
Apr 28, 2026
completion
Sep 30, 2026
last updated
Aug 3, 2026
official title
A Multicenter, Randomized, Double-Blind, Active Drug/Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of ASKC200 in Patients With Knee Osteoarthritis Pain
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol